ClinicalTrials.Veeva

Menu

CGM Use in Poorly Controlled Youth With Type 1 Diabetes (IMPaCT)

Johns Hopkins University logo

Johns Hopkins University

Status

Completed

Conditions

Hypoglycemia
Type 1 Diabetes
High Blood Sugar

Treatments

Device: Dexcom G6 Continuous Glucose Monitor

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT04721145
IRB00255470

Details and patient eligibility

About

The purpose of this prospective study is to determine if trial use of a Dexcom G6 CGM system for a 10 day wear period in high risk, poorly controlled pediatric Type 1 diabetes patients increases uptake of personal CGM use, and improves short-term time in range glucose control.

Enrollment

26 patients

Sex

All

Ages

5 to 21 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of Type 1 diabetes for >3 months

Exclusion criteria

  • CGM use in the last 6 months

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

26 participants in 1 patient group

Dexcom G6 Continuous Glucose Monitor
Experimental group
Description:
Children with type 1 diabetes will wear a continuous glucose monitor (CGM) for 10 days.
Treatment:
Device: Dexcom G6 Continuous Glucose Monitor

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems